Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2023-05-02 00:00:00 ET · period of report 2023-05-01 · accession 0001069530-23-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-02 | 2023-05-01 | FLNA | GUSSIN ROBERT Z | Dir | M - OptEx | $17.79 | +9,284 | 10.6K | +732% | +$165.2K |
| D | 2023-05-02 | 2023-05-01 | FLNA | GUSSIN ROBERT Z | Dir | F - Tax | $23.34 | +7,077 | 10.6K | +200% | +$165.2K |
| DM | 2023-05-02 | 2023-05-01 | FLNA | GUSSIN ROBERT Z | Dir | M - OptEx | $17.79 | -9,284 | 0 | -100% | -$165.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | M | A | 3,571 | $19.60 | 17,694 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-01 | M | A | 3,571 | $16.66 | 14,123 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-01 | M | A | 2,142 | $16.66 | 10,552 | D | — | — | |
| 4 | Common | Common Stock | 2023-05-01 | F | A | 7,077 | $23.34 | 10,617 | D | — | — | (F1) Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-05-01 | M | D | 3,571 | $19.60 | 0 | D | $19.60 · 2017-05-16 to 2023-05-16 | 3,571 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-05-01 | M | D | 3,571 | $16.66 | 0 | D | $16.66 · 2017-06-14 to 2023-06-14 | 3,571 Common Stock | |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-05-01 | M | D | 2,142 | $16.66 | 0 | D | $16.66 · 2017-06-14 to 2023-06-14 | 2,142 Common Stock |